Corriente Advisors LLC 13D/13G Filings for Cue Biopharma, Inc. (CUE)

Corriente Advisors LLC 13D and 13G filings for Cue Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
4:23 pm
Sale		 2021-12-31 13G Cue Biopharma, Inc.
CUE		 Corriente Advisors LLC 0
0.000%		 -1,915,219decrease
(Position Closed)		 Filing
2021-02-16
06:28 am
Purchase		 2020-12-31 13G Cue Biopharma, Inc.
CUE		 Corriente Advisors LLC 1,915,219
6.330%		 1,915,219increase
(New Position)		 Filing